13851311000001109: Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\UK product\Virtual medicinal product\Product containing precisely thalidomide 50 milligram/1 each conventional release oral capsule\Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Thalidomide\Product containing only thalidomide in oral dose form (medicinal product form)\Product containing precisely thalidomide 50 milligram/1 each conventional release oral capsule\Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\UK product\Virtual therapeutic moiety\Thalidomide\Product containing precisely thalidomide 50 milligram/1 each conventional release oral capsule\Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing thalidomide\Thalidomide\Product containing only thalidomide in oral dose form (medicinal product form)\Product containing precisely thalidomide 50 milligram/1 each conventional release oral capsule\Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing thalidomide\Thalidomide\Product containing precisely thalidomide 50 milligram/1 each conventional release oral capsule\Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing thalidomide\Product containing thalidomide in oral dose form (medicinal product form)\Product containing only thalidomide in oral dose form (medicinal product form)\Product containing precisely thalidomide 50 milligram/1 each conventional release oral capsule\Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing piperidine derivative\Product containing thalidomide\Thalidomide\Product containing only thalidomide in oral dose form (medicinal product form)\Product containing precisely thalidomide 50 milligram/1 each conventional release oral capsule\Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing piperidine derivative\Product containing thalidomide\Thalidomide\Product containing precisely thalidomide 50 milligram/1 each conventional release oral capsule\Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing piperidine derivative\Product containing thalidomide\Product containing thalidomide in oral dose form (medicinal product form)\Product containing only thalidomide in oral dose form (medicinal product form)\Product containing precisely thalidomide 50 milligram/1 each conventional release oral capsule\Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing thalidomide in oral dose form (medicinal product form)\Product containing only thalidomide in oral dose form (medicinal product form)\Product containing precisely thalidomide 50 milligram/1 each conventional release oral capsule\Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2405881000001116 Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2405891000001119 Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Product containing precisely thalidomide 50 milligram/1 each conventional release oral capsule	true	Inferred relationship	Existential restriction modifier
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has active ingredient	Thalidomide	false	Inferred relationship	Existential restriction modifier
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has manufactured dose form	Capsule	false	Inferred relationship	Existential restriction modifier
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has manufactured dose form	Conventional release oral capsule	true	Inferred relationship	Existential restriction modifier
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has excipient	Lactose	true	Inferred relationship	Existential restriction modifier
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has specific active ingredient	Thalidomide	true	Inferred relationship	Existential restriction modifier
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Has dispensed dose form	Capsule	true	Inferred relationship	Existential restriction modifier
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 capsule 2 x 14 capsules	Is pack of	False	Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier
Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 capsule 2 x 14 capsules	Has AMP	True	Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2405881000001116	Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2405891000001119	Thalidomide BMS 50mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module